News Global Priority Statement: Integrate Hepatitis B Responses into Harm Reduction A Viral Hepatitis Pre-Conference was convened as part of the Harm Reduction International 2023 Conference in Melbourne, Australia, situated in the Western Pacific Region which has the highest prevalence of hepatitis B in the world.⯠People who use drugs have the right to be protected from hepatitis B infection, to know their hepatitis B status, and to have equitable and affordable access to prevention, treatment and care.⯠People who use drugs are significantly and disproportionately affected by the health and social impacts of hepatitis B,âŻhowever to-date hepatitis B has been neglected in harm reduction programs and policies.⯠Download the statement Manage Cookie Preferences